Torrent Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

169.23

169.23

84.62

84.62

84.62

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

6,659.53

6,286.73

6,260.80

5,945.48

5,036.35

Loan funds

Secured loans

3,332.96

4,565.56

3,343.41

4,384.43

3,913.76

Unsecured loans

-

-

-

-

-

Total

10,161.72

11,021.52

9,688.83

10,414.53

9,034.73

Uses of funds

Fixed assets

Gross block

9,880.47

9,693.59

7,794.90

8,135.03

8,386.11

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

1,894.55

1,721.74

1,543.65

1,393.79

1,188.61

Net block

7,985.92

7,971.85

6,251.25

6,741.24

7,197.50

Capital work-in-progress

226.23

697.93

567.50

588.11

536.41

Investments

463.31

361.21

367.64

313.92

134.89

Net current assets

Current assets, loans & advances

3,701.13

3,840.94

3,966.17

4,117.77

4,015.67

Less : current liabilities & provisions

2,214.87

1,850.41

1,463.73

1,346.51

2,849.74

Total net current assets

1,486.26

1,990.53

2,502.44

2,771.26

1,165.93

Miscellaneous expenses not written

-

-

-

-

-

Total

10,161.72

11,021.52

9,688.83

10,414.53

9,034.73

Notes:

Book value of unquoted investments

322.27

361.18

367.64

313.92

134.87

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

1,395.40

1,448.95

1,296.42

1,155.38

325.37

Number of equity sharesoutstanding (Lacs)

3384.45

3384.45

1692.23

1692.23

1692.23